Navigation Links
Ameritox Data on ADHD Stimulant Prescriptions Uncovers Significant Rates of Illicit Drug Use and Potential Nonadherence to Drug Regimen
Date:1/18/2016

WASHINGTON, Jan. 18, 2016 /PRNewswire/ -- AmeritoxSM, a national leader in medication monitoring solutions, presented new research showing that in one out of three samples of patients prescribed stimulants to treat attention-deficit/hyperactivity (ADHD) disorder the prescribed drug was not detected. Members of Ameritox's Medical Affairs team prepared the data for attendees at the American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting, held in Washington, where conference organizers highlighted the Ameritox report for attendees.

Logo - http://photos.prnewswire.com/prnh/20160115/322830LOGO

Based on samples collected from more than 4,000 patients between July 1, 2014 and June 30, 2015, the Ameritox data showed indications that potential nonadherence to prescription stimulants in the treatment of ADHD is associated with elevated rates of illicit drug use as well as non-medical use of opioids and benzodiazepines. In samples where the prescribed stimulant was not detected, THC was present more than 20 percent of the time. Nearly four in ten samples where the prescribed stimulant was not detected tested positive for some combination of a nonprescribed opioid, nonprescribed benzodiazepine, THC and/or cocaine.

In addition, patients being treated for ADHD with prescription stimulants showed high rates of potential nonadherence across all age groups. Patients over the age of 60 showed the lowest rates of potential nonadherence, with 24.4 percent of samples absent the prescribed drug. Patients between ages 20 and 29 had the highest rates of potential nonadherence, as more than 40 percent of all samples collected from patients in that age range tested negative for their prescribed stimulant.

"Even in the best case scenarios," said Ameritox Chief Medical Officer Dr. Tom Smith, "the potential for diversion or illicit drug use is alarmingly high. The misuse, abuse and diversion of ADHD medications cannot be casually brushed aside when these results suggest that even when the prescribed ADHD medication is found there is a nearly one in four chance that the sample will also test positive for potentially dangerous substances."

About Ameritox 
Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

Visit the Ameritox website at: www.ameritox.com 
Follow Ameritox on Twitter: www.twitter.com/ameritox

Contact: Lon Wagner 
Director of Communications, Ameritox 
(336) 387-7742 
Email

Josh Silberberg 
30 Point Strategies 
202-304-1546 
Email

 


'/>"/>
SOURCE Ameritox
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Ameritox Wins Award for Compliance Training
2. Ameritox Advocate and Former DEA Special Agent to Lead Symposium on Preventing Prescription Opioid and Heroin Abuse in Local Community
3. Ameritox Research Shows Wide Variety of Potential Misuse and Abuse of Other Medications and Drugs in Those Prescribed Opioids
4. Ameritox Delivers Testimony Before Maryland Heroin and Opioid Emergency Task Force
5. Ameritox Appoints New Chief Medical Officer
6. Ameritox Research Report Reveals Pain Patients Role in Current Heroin Epidemic
7. Ameritox and Ingenuity Health Building Comprehensive Reference Database to Help Assess Medication Adherence in those with Serious Mental Illness
8. Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
9. Natural Process Green Coffee Bean Extract Promises Safe, Effective Weight Loss Without Stimulants or Unhealthy Additives
10. Meijer Gives Away 30 Million Free Prescriptions Since 2006
11. Prime Therapeutics and CoverMyMeds Help Lower the Number of High-Risk Medication Prescriptions for Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):